Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
778
Employees778
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
778
Employees778

SUPN Key Statistics

Market cap
2.88B
Market cap2.88B
Price-Earnings ratio
-72.76
Price-Earnings ratio-72.76
Dividend yield
Dividend yield
Average volume
455.31K
Average volume455.31K
High today
$50.11
High today$50.11
Low today
$49.27
Low today$49.27
Open price
$49.73
Open price$49.73
Volume
158.62K
Volume158.62K
52 Week high
$59.68
52 Week high$59.68
52 Week low
$29.16
52 Week low$29.16

Stock Snapshot

Supernus Pharmaceuticals(SUPN) stock is priced at $49.93, giving the company a market capitalization of 2.88B. It carries a P/E multiple of -72.76.

During the trading session on 2026-04-27, Supernus Pharmaceuticals(SUPN) shares reached a daily high of $50.11 and a low of $49.27. At a current price of $49.93, the stock is +1.3% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 158.62K, compared to an average daily volume of 455.31K.

Over the past 52 weeks, Supernus Pharmaceuticals(SUPN) stock has traded between a high of $59.68 and a low of $29.16.

Over the past 52 weeks, Supernus Pharmaceuticals(SUPN) stock has traded between a high of $59.68 and a low of $29.16.

SUPN News

Simply Wall St 3d
A Look At Supernus Pharmaceuticals Valuation After Strong Recent Shareholder Returns

Supernus Pharmaceuticals (SUPN) has drawn fresh attention as investors reassess its role in treating central nervous system conditions, with returns over the pa...

A Look At Supernus Pharmaceuticals Valuation After Strong Recent Shareholder Returns

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.